Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes R Brauer, L Wei, T Ma, D Athauda, C Girges, N Vijiaratnam, G Auld, ... Brain 143 (10), 3067-3076, 2020 | 160 | 2020 |
Video-based analyses of Parkinson’s disease severity: a brief review KG Sibley, C Girges, E Hoque, T Foltynie Journal of Parkinson's disease 11 (s1), S83-S93, 2021 | 63 | 2021 |
The Impact of Type 2 Diabetes in Parkinson's Disease D Athauda, J Evans, A Werwick, G Virdi, M Liane-Choi, M Lawton, ... | 56* | |
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group … N Vijiaratnam, C Girges, G Auld, M Chau, K Maclagan, A King, S Skene, ... BMJ open 11 (5), e047993, 2021 | 51 | 2021 |
Categorizing identity from facial motion C Girges, J Spencer, J O'Brien Quarterly Journal of Experimental Psychology 68 (9), 1832-1843, 2015 | 32 | 2015 |
Impaired perception of facial motion in autism spectrum disorder J O’Brien, J Spencer, C Girges, A Johnston, H Hill PLoS One 9 (7), e102173, 2014 | 29 | 2014 |
Seizures triggered by eating-a rare form of reflex epilepsy: a systematic review C Girges, N Vijiaratnam, T Wirth, C Tjoakarfa, J Idaszak, U Seneviratne Seizure 83, 21-31, 2020 | 18 | 2020 |
Combining biomarkers for prognostic modelling of Parkinson’s disease N Vijiaratnam, M Lawton, AJ Heslegrave, T Guo, M Tan, E Jabbari, R Real, ... Journal of Neurology, Neurosurgery & Psychiatry 93 (7), 707-715, 2022 | 17 | 2022 |
Event-related alpha suppression in response to facial motion C Girges, MJ Wright, JV Spencer, JMD O’Brien PLoS One 9 (2), e89382, 2014 | 17 | 2014 |
An evaluation of KELVIN, an artificial intelligence platform, as an objective assessment of the MDS UPDRS part III K Sibley, C Girges, J Candelario, C Milabo, M Salazar, JO Esperida, ... Journal of Parkinson's Disease 12 (7), 2223-2233, 2022 | 12 | 2022 |
The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability C Girges, N Vijiaratnam, D Athauda, G Auld, S Gandhi, T Foltynie Drugs & Aging, 1-19, 2021 | 12 | 2021 |
Volitional control of brain motor activity and its therapeutic potential C Girges, N Vijiaratnam, L Zrinzo, J Ekanayake, T Foltynie Neuromodulation: Technology at the Neural Interface 25 (8), 1187-1196, 2022 | 11 | 2022 |
Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson’s disease depends on tremor severity and symptom duration N Vijiaratnam, C Girges, T Wirth, T Grover, F Preda, E Tripoliti, J Foley, ... Brain Communications 3 (3), fcab165, 2021 | 9 | 2021 |
Diabetes and neuroaxonal damage in Parkinson's disease N Vijiaratnam, M Lawton, R Real, AJ Heslegrave, T Guo, D Athauda, ... Movement Disorders 37 (7), 1568-1569, 2022 | 6 | 2022 |
Neural correlates of facial motion perception C Girges, J O’Brien, J Spencer Social Neuroscience 11 (3), 311-316, 2016 | 6 | 2016 |
Seizures triggered by eating: a rare form of reflex epilepsy N Vijiaratnam, C Girges, J Idaszak, U Seneviratne Epileptic Disorders 22 (5), 648-653, 2020 | 4 | 2020 |
Automated PDF highlighting to support faster curation of literature for Parkinson’s and Alzheimer’s disease H Wu, A Oellrich, C Girges, B de Bono, TJP Hubbard, RJB Dobson Database 2017, bax027, 2017 | 3 | 2017 |
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐to Mid‐Stage Parkinson's Disease Modification Trials N Vijiaratnam, C Girges, D Athauda, A King, G Auld, R McComish, ... Movement Disorders Clinical Practice, 2024 | | 2024 |
GLP-1 receptor agonism ameliorates Parkinsons disease through modulation of neuronal insulin signalling and glial suppression D Athauda, JR Evans, L Sanchez, G Virdi, P Lopez Garcia, A Wernick, ... bioRxiv, 2024.02. 28.582460, 2024 | | 2024 |
Brain Oedema Associated with Deep Brain Stimulation through a Single Directional Contact C Girges, MT Krüger, H Akram, J Hyam, P Limousin, L Zrinzo, T Foltynie Movement Disorders Clinical Practice 10 (11), 1695, 2023 | | 2023 |